Monoclonal antibody treatment for COVID-19, like the one from Regeneron, isn’t a traditional drug. It’s tough to make in the lab.
Source: The Daily News
Why monoclonal antibodies are expensive and hard to make in the fight against COVID-19.
Monoclonal antibody treatment for COVID-19, like the one from Regeneron, isn’t a traditional drug. It’s tough to make in the lab.
Source: The Daily News